Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

Fig. 5

Systolic blood pressure, LDL-cholesterol level and predicted 10-year CVD risk over time in the usual care and intervention groups. Measurements at t = 0 were performed at the first visit. Error bars depict the 95% confidence interval of the mean. CVD cardiovascular disease, ITT intention-to-treat, LDL low-density lipoprotein, PP per-protocol

Back to article page